Louviere, Stratton & Yokel is an architecture firm that specializes in designing animal research facilities. They provide planning, design, and construction services for clients in government, academia, and the private sector. The firm is nationally recognized for its expertise in areas like biocontainment laboratories and animal facilities. It distinguishes itself by combining small firm responsiveness with expertise found at larger national firms.
This document summarizes a scientific paper that analyzed the genome of the sea urchin to gain insights into its immune system. The analysis of the sea urchin genome revealed a diverse set of immune genes similar to those found in jawed vertebrates. This suggests the sea urchin has a complex immune system reliant on specialized immune cells. The findings provide a more in-depth understanding of the evolution of the immune system in invertebrate animals.
Joint presentation by International Society for Biological and Environmental Repositories (ISBER) and European, Middle Eastern & African Society for Biopreservations & Biobanking (ESBB) at the EU Science: Global Challenges, Global Collaboration Conference held March 4-8, 2013 in Brussels, Belgium. The session on biobanking included presentations from BBMRI, P3G, ISBER/ESBB, BioShare, Nat. China Biobank and a discussion on ethical/legal issues in biobanking focusing on the current plan for the EU data protection regulations. The presentation was authored by Rita Lawlor, President ESBB; and Marianne Henderson, ISBER Past President.
The document discusses challenges around patenting genetic diagnostic techniques and genes. It summarizes recent court cases related to patent eligibility and examines empirical evidence on how gene patents have impacted access to genetic testing. Studies found that exclusivity through patents was often unnecessary for test development and led to reduced access, narrowing of testing options, and failure to incorporate new science. The document considers policy options to address these issues, such as excluding simple diagnostic techniques and genes from patentability or creating defenses that allow use for research or patient care. It also proposes new institutional arrangements to improve transparency, access, and oversight of gene patents.
Dr. Edward Kai-Hua Chow, JALA Associate Editor/Asia and National University of Singapore, shares his SLAS2013 JALA and JBS Authors Workshop presentation. Learn more about these leading peer-reviewed journals, and then see Ed's tips for publication beginning on slide 16.
The document discusses data requirements and standards for human tissue biobanks. It outlines regulations for inspecting statutory records related to human tissue under the Human Tissue Act. It also describes standards set by the Human Tissue Authority and National Cancer Research Institute for collecting and managing participant data, staff training, documentation, and quality assurance in biobanks. Historical issues with varying consent forms are discussed, as are efforts to standardize data sharing between biobanks through initiatives like MIABIS and the NCRI Biobank Data Standard. Progress on a combined surgical and research consent form is also mentioned.
Louviere, Stratton & Yokel is an architecture firm that specializes in designing animal research facilities. They provide planning, design, and construction services for clients in government, academia, and the private sector. The firm is nationally recognized for its expertise in designing high-tech laboratories for animal research, including biocontainment facilities. They emphasize collaboration with scientists to create innovative, functional spaces that meet client needs.
Louviere, Stratton & Yokel is an architecture firm that specializes in designing animal research facilities. They provide planning, design, and construction services for clients in government, academia, and the private sector. They are recognized experts in facilities for biocontainment laboratories, animal research spaces, imaging centers, and clinical spaces. The firm believes in collaborative design that produces innovative, aesthetic spaces tailored to client needs.
This document summarizes a scientific paper that analyzed the genome of the sea urchin to gain insights into its immune system. The analysis of the sea urchin genome revealed a diverse set of immune genes similar to those found in jawed vertebrates. This suggests the sea urchin has a complex immune system reliant on specialized immune cells. The findings provide a more in-depth understanding of the evolution of the immune system in invertebrate animals.
Joint presentation by International Society for Biological and Environmental Repositories (ISBER) and European, Middle Eastern & African Society for Biopreservations & Biobanking (ESBB) at the EU Science: Global Challenges, Global Collaboration Conference held March 4-8, 2013 in Brussels, Belgium. The session on biobanking included presentations from BBMRI, P3G, ISBER/ESBB, BioShare, Nat. China Biobank and a discussion on ethical/legal issues in biobanking focusing on the current plan for the EU data protection regulations. The presentation was authored by Rita Lawlor, President ESBB; and Marianne Henderson, ISBER Past President.
The document discusses challenges around patenting genetic diagnostic techniques and genes. It summarizes recent court cases related to patent eligibility and examines empirical evidence on how gene patents have impacted access to genetic testing. Studies found that exclusivity through patents was often unnecessary for test development and led to reduced access, narrowing of testing options, and failure to incorporate new science. The document considers policy options to address these issues, such as excluding simple diagnostic techniques and genes from patentability or creating defenses that allow use for research or patient care. It also proposes new institutional arrangements to improve transparency, access, and oversight of gene patents.
Dr. Edward Kai-Hua Chow, JALA Associate Editor/Asia and National University of Singapore, shares his SLAS2013 JALA and JBS Authors Workshop presentation. Learn more about these leading peer-reviewed journals, and then see Ed's tips for publication beginning on slide 16.
The document discusses data requirements and standards for human tissue biobanks. It outlines regulations for inspecting statutory records related to human tissue under the Human Tissue Act. It also describes standards set by the Human Tissue Authority and National Cancer Research Institute for collecting and managing participant data, staff training, documentation, and quality assurance in biobanks. Historical issues with varying consent forms are discussed, as are efforts to standardize data sharing between biobanks through initiatives like MIABIS and the NCRI Biobank Data Standard. Progress on a combined surgical and research consent form is also mentioned.
Louviere, Stratton & Yokel is an architecture firm that specializes in designing animal research facilities. They provide planning, design, and construction services for clients in government, academia, and the private sector. The firm is nationally recognized for its expertise in designing high-tech laboratories for animal research, including biocontainment facilities. They emphasize collaboration with scientists to create innovative, functional spaces that meet client needs.
Louviere, Stratton & Yokel is an architecture firm that specializes in designing animal research facilities. They provide planning, design, and construction services for clients in government, academia, and the private sector. They are recognized experts in facilities for biocontainment laboratories, animal research spaces, imaging centers, and clinical spaces. The firm believes in collaborative design that produces innovative, aesthetic spaces tailored to client needs.
Rong Chen is an expert in clinical genome informatics with 16 years of experience. He has built clinical genome informatics teams at Mount Sinai and Personalis. He has launched startups and developed NGS products for precision medicine. He has published over 70 papers and invented many patents. He received his Ph.D. from Boston University and has held positions at various academic and industry research laboratories.
UC Davis Translational Modeling BrochureElizabeth Fox
The document describes several research centers and capabilities at UC Davis related to clinical trials and regenerative medicine. It notes that veterinary clinical trials using companion animals can better reflect human genetic and environmental variability and shorten the path to human trials. The Veterinary Center for Clinical Trials conducts such veterinary trials. It also describes the $62 million Veterinary Institute for Regenerative Cures that has facilities for stem cell research and projects in osteoporosis, Huntington's disease, limb ischemia, and stem cell airway transplants. Additionally, UC Davis has a Comprehensive Cancer Center, Clinical and Translational Science Center, and is among the first 12 institutions to receive an NIH Clinical Translational Science Award to improve health and healthcare
Yury scherbak development of scientific technical platfroms in a firald of bi...igorod
The document discusses the development of scientific-technical platforms in biomedicine. It proposes platforms focused on specific nosological and technological groups, such as oncology and autoimmune diseases. One such platform discussed is for personalized diagnosis and treatment of cancer. This platform involves various participants conducting research into risk identification, diagnostics, noninvasive tumor cell extraction, targeted therapy, and development of personalized medicines. The goal is to create a unified system in Russia for cancer diagnosis through personalized treatment.
CHI’s Thirteenth Annual High-Content Analysis meeting, the premier event showcasing the latest advancements in HCA applications and technologies, returns to San Diego with a new program. Over the years we have observed the technology mature and its adoption spread into many areas of compound screening/evaluation and functional analysis. The High-Content Analysis meeting will focus on the next steps of technology development, including screening of 3D and physiologically relevant complex models, ultra-high resolution and high-throughput imaging, more advanced image analysis and data management, and new assays and applications. The co-located Second Annual Phenotypic Screening meeting will address the advantages of phenotypic screening vs. target-based screening, and focus on assay development, selection of physiologically relevant models and subsequent target identification, as well as case studies of phenotypic screens from leading pharma. Join the original High-Content Analysis event and get access to two tracks featuring a cutting-edge scientific agenda, expanded exhibit hall and technology showcases, and an offering of technology demonstrations and dinner courses.
The National Institute for Occupational Safety and Health (NIOSH) is the U.S. agency responsible for conducting research to prevent work-related injury and illness. NIOSH provides resources for safe nanotechnology including guidance documents, a nanoparticle information library, reference materials, training, and recommendations for further research needs such as developing methods to detect nanomaterials and characterize their properties. NIOSH also conducts field research at organizations working with nanomaterials to assess exposures, practices, and make recommendations to update their guidance.
Biosample exchanges – the past, the current and the future – how do we make i...Pistoia Alliance
This document summarizes a panel discussion on biosample exchanges between experts from pharmaceutical companies and universities. It discusses challenges in accessing suitable biosamples for research due to issues like outdated sample collection methods, incomplete data and consents. Two main approaches for centralizing biosample resources - hub and spoke collections and catalog approaches - are described. A pharmaceutical company perspective emphasizes needs like well-annotated samples, archived data, quick turnaround times and quality measures. The role of the UKCRC Tissue Directory in facilitating discovery and access of tissue samples through an online directory is also briefly outlined.
Biobanks provide essential resources for translational and clinical research by collecting and storing biological samples and associated data. However, there are challenges to establishing sustainable biobanks, including managing stakeholders, standardizing operations, ensuring quality, and balancing the demand for samples with a biobank's finite collection and storage capacity. Centralized biobanks can help address these challenges through economies of scale, uniform standards and regulations, dedicated expertise and facilities, and coordinated access policies that serve researchers' needs while protecting research subjects.
The document outlines various resources and programs available through the National Institutes of Health (NIH) to support research and development efforts, from early stage screening and validation to late stage clinical trials. It describes screening programs, technology characterization services, preclinical and clinical development resources across multiple NIH institutes focused on areas like cancer, neurodegeneration, infectious diseases, and more. The document encourages collaborations between NIH researchers and outside entities through licensing agreements, cooperative research agreements, and material transfers to help move technologies toward public health benefits.
The document discusses the National Center for Biotechnology Information (NCBI). It provides background that NCBI is part of the National Library of Medicine and houses databases relevant to biotechnology and biomedicine. It describes some of NCBI's major databases, including GenBank for DNA sequences and PubMed for biomedical literature. The document also discusses the BLAST tool and provides examples of some of NCBI's databases, such as the Nucleotide, Protein, and Structural databases.
This file includes the SLAS2013 presentations of Paul A. Johnston of University of Pittsburgh; Douglas Auld of Novartis Institutes for Biomedical Research; and Lisa Minor of In Vitro Strategies, LLC.
SMi Group's 7th annual Advances in Cell Based Assays conferenceDale Butler
This document summarizes a two-day conference on advances in cell-based assays being held on November 11-12, 2014 in London. The conference will explore the latest developments in cell-based assays and their application in drug discovery and development. Speakers will include representatives from pharmaceutical companies such as GSK, AstraZeneca, Novartis, UCB, and Merck Serono, as well as academics. Topics will include the use of cell-based assays in biologics drug discovery, challenges in validation and regulation, phenotypic screening, stem cell technologies, and 3D cell cultures. Workshops on leveraging cell-based assays for open innovation and evaluating cell-based assays in drug discovery will also be offered
Join us in Boston this coming Fall to attend Cambridge Healthtech Institute's (CHI) 2nd Annual FAST: Functional Analysis & Screening Technologies Congress on November 17-19, 2014 and meet with a community of 250+ biologists, screening managers, assay developers, engineers and pharmacologists dedicated to improving in vitro cell models and phenotypic screening to advance drug discovery and development at 6 conferences: Phenotypic Drug Discovery (Part I & II), Engineering Functional 3D Models, Screening and Functional Analysis of 3D Models, Organotypic Culture Models for Toxicology and Physiologically-Relevant Cellular Tumor Models for Drug Discovery. Delegates have the opportunity to share insights in interactive panel discussions and connect during networking breaks. View innovative technologies and scientific research revolutionizing early-stage drug discovery in the exhibit/poster hall.
The document provides an overview of the College of Veterinary Medicine and Biomedical Sciences at Colorado State University. It summarizes that CVMBS has over 225 faculty conducting over $50 million in research annually across various departments and areas of emphasis including animal health, infectious diseases, and one health initiatives. It also outlines ongoing partnerships between CVMBS and the University of Nairobi in Kenya to collaborate on research and training opportunities in areas like veterinary diagnostics and epidemiology.
Ryan Spitler has extensive experience in research related to cellular and molecular biosciences. He is currently a Ph.D. student at UC Irvine developing models to study smoke inhalation damage. Previously he worked at Stanford developing imaging systems and conducting research on wound healing and lung damage therapeutics. He has authored several publications related to drug delivery and RNAi therapeutics.
Bioinformatics introduction of biological database (NCBI), Introduction to bioinformatics.
major bioinformatics database.
important database of bioinformatics
UNESP is a public university system in São Paulo, Brazil with 23 campuses across the state. It has over 35,000 undergraduate students and 15,000 graduate students enrolled in a wide range of programs. UNESP focuses on research excellence in fields like bioenergy, ocean science, biomaterials, and biotechnology through its various research centers and institutes. It contributes significantly to the development of São Paulo through education, research, and partnerships.
This presentation by Pressure BioSciences discusses their Pressure Cycling Technology platform for biological sample preparation. Some key points:
- PCT uses ultra-high pressure to break up cell walls and extract biomolecules, achieving better results than mechanical methods.
- The market for biological sample preparation is multi-billion dollars. PCT addresses the need for improved sample prep methods.
- Over 275 PCT systems have been installed at over 150 customer sites. There are over 100 publications highlighting PCT's advantages.
- Recent accomplishments include a co-marketing agreement with SCIEX, a leader in analytical technologies, and sales of their new Barocycler 2320EXTREME system.
This document provides a summary of a presentation on utilizing health data from across the University of California system to enable precision medicine research and applications. It notes that the UC Health system has over 700 trillion data points from electronic health records, genomics, imaging, and other sources from its six medical centers. This data is being housed in a centralized data warehouse to allow integrated analysis. The speaker discusses several early applications including diabetes research, COVID research, and clinical decision support. Collaborations with other academic institutions are also mentioned.
Rong Chen is an expert in clinical genome informatics with 16 years of experience. He has built clinical genome informatics teams at Mount Sinai and Personalis. He has launched startups and developed NGS products for precision medicine. He has published over 70 papers and invented many patents. He received his Ph.D. from Boston University and has held positions at various academic and industry research laboratories.
UC Davis Translational Modeling BrochureElizabeth Fox
The document describes several research centers and capabilities at UC Davis related to clinical trials and regenerative medicine. It notes that veterinary clinical trials using companion animals can better reflect human genetic and environmental variability and shorten the path to human trials. The Veterinary Center for Clinical Trials conducts such veterinary trials. It also describes the $62 million Veterinary Institute for Regenerative Cures that has facilities for stem cell research and projects in osteoporosis, Huntington's disease, limb ischemia, and stem cell airway transplants. Additionally, UC Davis has a Comprehensive Cancer Center, Clinical and Translational Science Center, and is among the first 12 institutions to receive an NIH Clinical Translational Science Award to improve health and healthcare
Yury scherbak development of scientific technical platfroms in a firald of bi...igorod
The document discusses the development of scientific-technical platforms in biomedicine. It proposes platforms focused on specific nosological and technological groups, such as oncology and autoimmune diseases. One such platform discussed is for personalized diagnosis and treatment of cancer. This platform involves various participants conducting research into risk identification, diagnostics, noninvasive tumor cell extraction, targeted therapy, and development of personalized medicines. The goal is to create a unified system in Russia for cancer diagnosis through personalized treatment.
CHI’s Thirteenth Annual High-Content Analysis meeting, the premier event showcasing the latest advancements in HCA applications and technologies, returns to San Diego with a new program. Over the years we have observed the technology mature and its adoption spread into many areas of compound screening/evaluation and functional analysis. The High-Content Analysis meeting will focus on the next steps of technology development, including screening of 3D and physiologically relevant complex models, ultra-high resolution and high-throughput imaging, more advanced image analysis and data management, and new assays and applications. The co-located Second Annual Phenotypic Screening meeting will address the advantages of phenotypic screening vs. target-based screening, and focus on assay development, selection of physiologically relevant models and subsequent target identification, as well as case studies of phenotypic screens from leading pharma. Join the original High-Content Analysis event and get access to two tracks featuring a cutting-edge scientific agenda, expanded exhibit hall and technology showcases, and an offering of technology demonstrations and dinner courses.
The National Institute for Occupational Safety and Health (NIOSH) is the U.S. agency responsible for conducting research to prevent work-related injury and illness. NIOSH provides resources for safe nanotechnology including guidance documents, a nanoparticle information library, reference materials, training, and recommendations for further research needs such as developing methods to detect nanomaterials and characterize their properties. NIOSH also conducts field research at organizations working with nanomaterials to assess exposures, practices, and make recommendations to update their guidance.
Biosample exchanges – the past, the current and the future – how do we make i...Pistoia Alliance
This document summarizes a panel discussion on biosample exchanges between experts from pharmaceutical companies and universities. It discusses challenges in accessing suitable biosamples for research due to issues like outdated sample collection methods, incomplete data and consents. Two main approaches for centralizing biosample resources - hub and spoke collections and catalog approaches - are described. A pharmaceutical company perspective emphasizes needs like well-annotated samples, archived data, quick turnaround times and quality measures. The role of the UKCRC Tissue Directory in facilitating discovery and access of tissue samples through an online directory is also briefly outlined.
Biobanks provide essential resources for translational and clinical research by collecting and storing biological samples and associated data. However, there are challenges to establishing sustainable biobanks, including managing stakeholders, standardizing operations, ensuring quality, and balancing the demand for samples with a biobank's finite collection and storage capacity. Centralized biobanks can help address these challenges through economies of scale, uniform standards and regulations, dedicated expertise and facilities, and coordinated access policies that serve researchers' needs while protecting research subjects.
The document outlines various resources and programs available through the National Institutes of Health (NIH) to support research and development efforts, from early stage screening and validation to late stage clinical trials. It describes screening programs, technology characterization services, preclinical and clinical development resources across multiple NIH institutes focused on areas like cancer, neurodegeneration, infectious diseases, and more. The document encourages collaborations between NIH researchers and outside entities through licensing agreements, cooperative research agreements, and material transfers to help move technologies toward public health benefits.
The document discusses the National Center for Biotechnology Information (NCBI). It provides background that NCBI is part of the National Library of Medicine and houses databases relevant to biotechnology and biomedicine. It describes some of NCBI's major databases, including GenBank for DNA sequences and PubMed for biomedical literature. The document also discusses the BLAST tool and provides examples of some of NCBI's databases, such as the Nucleotide, Protein, and Structural databases.
This file includes the SLAS2013 presentations of Paul A. Johnston of University of Pittsburgh; Douglas Auld of Novartis Institutes for Biomedical Research; and Lisa Minor of In Vitro Strategies, LLC.
SMi Group's 7th annual Advances in Cell Based Assays conferenceDale Butler
This document summarizes a two-day conference on advances in cell-based assays being held on November 11-12, 2014 in London. The conference will explore the latest developments in cell-based assays and their application in drug discovery and development. Speakers will include representatives from pharmaceutical companies such as GSK, AstraZeneca, Novartis, UCB, and Merck Serono, as well as academics. Topics will include the use of cell-based assays in biologics drug discovery, challenges in validation and regulation, phenotypic screening, stem cell technologies, and 3D cell cultures. Workshops on leveraging cell-based assays for open innovation and evaluating cell-based assays in drug discovery will also be offered
Join us in Boston this coming Fall to attend Cambridge Healthtech Institute's (CHI) 2nd Annual FAST: Functional Analysis & Screening Technologies Congress on November 17-19, 2014 and meet with a community of 250+ biologists, screening managers, assay developers, engineers and pharmacologists dedicated to improving in vitro cell models and phenotypic screening to advance drug discovery and development at 6 conferences: Phenotypic Drug Discovery (Part I & II), Engineering Functional 3D Models, Screening and Functional Analysis of 3D Models, Organotypic Culture Models for Toxicology and Physiologically-Relevant Cellular Tumor Models for Drug Discovery. Delegates have the opportunity to share insights in interactive panel discussions and connect during networking breaks. View innovative technologies and scientific research revolutionizing early-stage drug discovery in the exhibit/poster hall.
The document provides an overview of the College of Veterinary Medicine and Biomedical Sciences at Colorado State University. It summarizes that CVMBS has over 225 faculty conducting over $50 million in research annually across various departments and areas of emphasis including animal health, infectious diseases, and one health initiatives. It also outlines ongoing partnerships between CVMBS and the University of Nairobi in Kenya to collaborate on research and training opportunities in areas like veterinary diagnostics and epidemiology.
Ryan Spitler has extensive experience in research related to cellular and molecular biosciences. He is currently a Ph.D. student at UC Irvine developing models to study smoke inhalation damage. Previously he worked at Stanford developing imaging systems and conducting research on wound healing and lung damage therapeutics. He has authored several publications related to drug delivery and RNAi therapeutics.
Bioinformatics introduction of biological database (NCBI), Introduction to bioinformatics.
major bioinformatics database.
important database of bioinformatics
UNESP is a public university system in São Paulo, Brazil with 23 campuses across the state. It has over 35,000 undergraduate students and 15,000 graduate students enrolled in a wide range of programs. UNESP focuses on research excellence in fields like bioenergy, ocean science, biomaterials, and biotechnology through its various research centers and institutes. It contributes significantly to the development of São Paulo through education, research, and partnerships.
This presentation by Pressure BioSciences discusses their Pressure Cycling Technology platform for biological sample preparation. Some key points:
- PCT uses ultra-high pressure to break up cell walls and extract biomolecules, achieving better results than mechanical methods.
- The market for biological sample preparation is multi-billion dollars. PCT addresses the need for improved sample prep methods.
- Over 275 PCT systems have been installed at over 150 customer sites. There are over 100 publications highlighting PCT's advantages.
- Recent accomplishments include a co-marketing agreement with SCIEX, a leader in analytical technologies, and sales of their new Barocycler 2320EXTREME system.
This document provides a summary of a presentation on utilizing health data from across the University of California system to enable precision medicine research and applications. It notes that the UC Health system has over 700 trillion data points from electronic health records, genomics, imaging, and other sources from its six medical centers. This data is being housed in a centralized data warehouse to allow integrated analysis. The speaker discusses several early applications including diabetes research, COVID research, and clinical decision support. Collaborations with other academic institutions are also mentioned.
2. F IRM I NTRODUCTION
Louviere, Stratton and Yokel, L.L.C. (LSY) provides planning,
design, and construction phase services to government, academic
and private sector clients. We are nationally recognized for our
expertise in high technology projects including biocontainment and
nanotechnology laboratories, animal facilities, imaging, and clinical
facilities.
Our design philosophy emphasizes the collaboration of architecture
and science to produce innovative, aesthetic facilities responsive to
client needs. We distinguish ourselves by combining small firm
responsiveness with expertise ordinarily found in larger national
firms. Each of our clients is assured of principal level involvement,
top flight service and innovative design from start to finish.
MISSION: The Principals at LSY share the common goal of
creating innovative and functional workspaces for the academic
and scientific research communities. LSY provides a wide range of
animal facilities planning and design services, including the design
of specialized spaces ranging from insectaries, imaging, and
aquatics facilities to biohazard containment vivaria and
laboratories BSL-2 through BSL-4.
We practice a knowledge-based team approach which respects and
encourages client participation. This philosophy is the cornerstone
on which LSY was founded and it continues to inspire our
commitment to innovative and functional design.
QUALITY: LSY has a proven track record of cost-efficient, on-time
delivery of technically-challenging laboratory and animal facilities.
We know the necessity of addressing today’s challenging security,
chain of command, and safety issues.
Our dedicated staff continually investigates the latest trends and
technologies in planning, programming and design, to achieve
maximum flexibility so that, as lab conditions and agendas evolve,
changing equipment needs and shifts in program emphasis may be
accommodated over the life of the building.
LOUVIERE, STRATTON & YOKEL, ARCHITECTS & LABORATORY PLANNERS
3. S ELECTED A NIMAL F ACILITY P ROJECTS
GEORGE MASON UNIVERSITY, KRASNOW INSTITUTE FOR ADVANCED STUDY
– planning and programming for two new additions totaling 28,000 sf, which
include a vivarium, neuroscience laboratories, and research offices.
CHILDREN’S NATIONAL MEDICAL CENTER RESEARCH EXPANSION –
planning and design for 6,000 sf expansion which will provide additional
holding, procedure rooms, and a state-of-the-art imaging center.
NIH JOHNS HOPKINS BAYVIEW RESEARCH CENTER -- design management
and peer review for 540,000 gsf basic research laboratory, including
approximately 65,000 nsf of primate and rodent vivarium.
NIH JOHN EDWARD PORTER NEUROSCIENCE RESEARCH CENTER -- design
management and peer review for 560,000 gsf basic research laboratory with
a 70,000 nsf vivarium.
NIH NATIONAL INSTITUTE OF ALLERGIES AND INFECTIOUS DISEASES -
planning, programming, and design oversight for 150,000 sf research facility
with BSL-3 containment laboratories and animal facilities for research on
infectious diseases.
NIH NATIONAL CANCER INSTITUTE BASIC RESEARCH LABORATORY --
renovation of 265,000 gsf occupied biomedical research facility, which
includes molecular biology, cellular biology, and genetics laboratories as well
as numerous specialized laboratories, and a rodent vivarium.
NIH ZEBRAFISH FACILITY -- planning and design of 16,500 sf zebrafish
aquatics vivarium and nuclear magnetic resonance facility. With 15,000
tanks, this zebrafish facility will be the largest in the world.
JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH – planning and
design for insect-borne infectious diseases laboratory and BSL-3 insectary.
NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH – master
planning and design for 55,000 sf research facility modernization, including
relocation of 8,000 sf transgenic vivarium with BSL-2 holding and procedure
facilities.
INTEGRATED LIFE SCIENCES BUILDING VIRGINA POLYTECHNIC INSTITUTE
AND STATE UNIVERSITY – laboratory planning for BSL-3 and BSL-2 facility
with 50,000 sf laboratories and a 7,300 sf rodent vivarium for infectious
disease research and vaccine development.
NATIONAL BIODEFENSE ANALYSIS AND COUNTERMEASURES CENTER
(NBACC) - planning and design for an 8,700 sf multi-species BSL-2 vivarium
with holding rooms, procedure space, surgery suite, telemetry room, and
support areas.
NIH ANIMAL CENTER RENOVATION- programming and design for 23,000 gsf
animal holding facility with a BSL-3 suite, holding, procedure, necropsy,
treatment, and laboratories.
FDA BSL-3 LABORATORY SUITE – planning and design for award-winning 700
sf animal holding suite for infectious disease research.
LOUVIERE, STRATTON & YOKEL, ARCHITECTS & LABORATORY PLANNERS
4. LSY V IVARIUM EXPERIENCE LSY C LIENT L IST
Army Corps of Engineers – Baltimore District
Baxter Bioscience
TYPE OF FACILITIES EXPERIENCE Cambridge Systems Inc.
• Multiple Species (rodents, rabbits, non-human Children’s National Medical Center
primates, etc.) Gallaudet University
• SPF, Transgenic, Barrier Facilities George Mason University
Georgetown University Hospital
• Biocontainment Facilities (BSL-3, 3Ag, 4)
Johns Hopkins University
• Specialized Facilities (Insectaries, Aerobiology, LifeBridge Health
Aquatics, Imaging, etc.)
Med Star Health
National Cancer Institute
Novartis Institutes for BioMedical Research, Inc.
SEMINARS / ASSOCIATIONS
The National Institutes of Health
• Member, American Association of Laboratory
National Center for Biotechnology Information
Animal Care – National Capital Area Branch
National Eye Institute
• Animal Facilities Design Seminars National Heart, Lung & Blood Institute
• Uniformed Services University of the Health National Human Genome Research Institute
Sciences National Institute of Allergy and Infectious Diseases
National Institute of Arthritis, Musculoskeletal and Skin Diseases
• Peer Reviewer, NCRR Grants Review Board
National Institute of Child Health and Human Development
• 2009 International Conference on National Institute of Dental and Craniofacial Research
Biocontainment Facilities National Institute of Diabetes and Digestive and Kidney Diseases
• 8th National CDC Symposium on Biosafety National Institute of Mental Health
• NIH Design Policy Guidelines: Technical Editor National Institute of Neurological Disorders and Stroke
Current Edition National Institute of Standards and Technology
National Institute on Alcohol Abuse and Alcoholism
• NIH/CDC Biomedical Manual for Biosafety:
Technical Editing Committee National Institute on Deafness and other Communications
Disorders
National Institutes of Health- National Center for Research
Resources
DESIGN REVIEW AUTHORITY
National Institute of Standards and Technology
• USAMRIID Peer Review
National Library of Medicine
• NIH National & Regional Biocontainment Rutgers University
Laboratories
Tufts University
• National Center for Research Resources (NCRR)
U.S. Food and Drug Administration
CO6 & G20 Construction Document Reviewer &
Site Inspections U.S. Naval Research Laboratory
University of Maryland Medical Center
University of Nebraska-Lincoln
University of North Dakota
University of Pittsburg Medical Center
Magee-Womens Research Institute
University of South Florida
University of Virginia
University of Washington
Virginia Commonwealth University
Virginia Polytechnic Institute and State University
Wright State University
Walter Reed Army Medical Center